Skip to main content
SHANGHAI MICROPORT EP MEDTECH CO., LTD. logo

SHANGHAI MICROPORT EP MEDTECH CO., LTD. — Investor Relations & Filings

Ticker · 688351 ISIN · CNE100005PG9 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 362 across all filing types
Latest filing 2025-03-27 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688351

About SHANGHAI MICROPORT EP MEDTECH CO., LTD.

https://www.everpace.com/

SHANGHAI MICROPORT EP MEDTECH CO., LTD. focuses on the research, development, and commercialization of medical devices for cardiac electrophysiology. The company provides a comprehensive suite of products for the diagnosis and treatment of cardiac arrhythmias, including 3D cardiac mapping systems, diagnostic catheters, and radiofrequency ablation catheters. Its core technology, the Columbus 3D EP Navigation System, enables precise localization and visualization of catheters within the heart. The product line also encompasses irrigation pumps and ablation generators designed to support minimally invasive procedures. The company aims to deliver integrated solutions that improve clinical outcomes for patients with rhythm disorders through advanced mapping and therapeutic technologies.

Recent filings

Filing Released Lang Actions
立信会计师事务所（特殊普通合伙）关于上海微创电生理医疗科技股份有限公司非经营性资金占用及其他关联资金往来情况的专项报告
Regulatory Filings
2025-03-27 Chinese
2024年年度业绩快报
Earnings Release Classification · 95% confidence The document is titled as a "2024 Annual Performance Express Report" (年度业绩快报) and contains preliminary unaudited financial data for the full year 2024, including revenue, profit, and other key financial metrics. It explicitly states that the data are preliminary and unaudited, and the final audited data will be in the company's 2024 Annual Report. The document is relatively short (1719 characters) and serves as a quick earnings summary rather than a full comprehensive report. This matches the characteristics of an Earnings Release (ER), which is an initial announcement of quarterly or annual financial results with key highlights only, not the full detailed annual report (10-K). Therefore, the correct classification is Earnings Release (ER). FY 2024
2025-02-24 Chinese
关于证券事务代表离职的公告
Board/Management Information Classification · 95% confidence The document is a short announcement regarding the resignation of a securities affairs representative from the company. It includes no financial data, no report content, and no mention of financial results or regulatory filings beyond the resignation notice. It is an announcement about a change in company personnel related to securities affairs, which falls under management or board information. Therefore, the document fits best under 'Board/Management Information' (MANG). The document length is short and does not contain any financial statements or report references, so it is not a report or regulatory filing.
2025-02-07 Chinese
2024年年度业绩预告
Earnings Release Classification · 95% confidence The document is a performance forecast for the fiscal year 2024, providing estimated net profit figures and explanations for changes compared to the previous year. It explicitly states that the forecast is unaudited and that the final audited financial data will be disclosed in the formal annual report. The document is short (1219 characters) and serves as a preliminary earnings guidance rather than a full financial report. It does not contain actual audited financial statements or detailed financial analysis. Therefore, it fits the category of an Earnings Release (ER), which is an initial announcement of periodic financial results or forecasts with key highlights only. FY 2024
2025-01-24 Chinese
2024年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a formal announcement of the resolutions passed at the 2024 first extraordinary general meeting of shareholders of Shanghai MicroPort EP MedTech Co., Ltd. It details the meeting date, attendance, voting results on specific proposals, and legal witness statements. The content focuses on the voting outcomes and procedural compliance rather than presenting a full report or financial statements. The document length is relatively short (2155 characters), and it serves as an official declaration of voting results from a shareholders' meeting. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2024-12-27 Chinese
北京世辉律师事务所关于上海微创电生理医疗科技股份有限公司2024年第一次临时股东大会的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the procedural legality and validity of a company's 2024 first extraordinary general meeting (临时股东大会). It details the convening, attendance, voting procedures, and results of the shareholders' meeting. It does not contain financial statements or management discussion but focuses on legal compliance and voting outcomes. The document is not an announcement of voting results per se, but a legal opinion on the meeting's conduct and results. Given the nature of the document as a legal opinion letter related to a shareholders' meeting, it best fits under Regulatory Filings (RNS), which covers miscellaneous regulatory announcements and compliance documents that do not fit other categories. The document length is under 5,000 characters, but it is not merely an announcement of a report publication, so RPA is not appropriate. It is not a proxy solicitation or voting results declaration, as it is a legal opinion rather than official voting results announcement. Therefore, the classification is RNS with high confidence.
2024-12-27 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.